PAUL J HASTINGS Insider Trading $TARA Protara Therapeutics, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for PAUL J HASTINGS.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of PAUL J HASTINGS. PAUL J HASTINGS is President & CEO in QLT INC/BC ($QLTI) and Chairman & CEO in OncoMed Pharmaceuticals Inc ($OMED) and Chief Executive Officer in OncoMed Pharmaceuticals Inc ($OMED) and Director in PROTEON THERAPEUTICS INC ($PRTO) and Director in Pacira Pharmaceuticals, Inc. ($PCRX) and Director in Relypsa Inc ($RLYP) and Chief Executive Officer in Nkarta, Inc. ($NKTX) and See Remarks in Nkarta, Inc. ($NKTX).

PAUL J HASTINGS in Protara Therapeutics, Inc.

Trading Symbol: TARA
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of PAUL J HASTINGS: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 11 2018
$TARA Market Capitalization: $31.94M
$TARA Previous Close: $1.95

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of PAUL J HASTINGS in Protara Therapeutics, Inc.

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, NKTX, NVLN, OMED, PCRX, TARA, RLYP

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares
Jun 11 2018	PRTO	PROTEON THERAPEUTI ...	HASTINGS PAUL J	Director	Option Exercise	A	2.50	12,700	31,750	12,700
Jun 21 2017	PRTO	PROTEON THERAPEUTI ...	HASTINGS PAUL J	Director	Option Exercise	A	1.30	6,666	8,666	6,666
Oct 20 2016	PRTO	PROTEON THERAPEUTI ...	HASTINGS PAUL J	Director	Option Exercise	A	9.00	13,333	119,997	13,333

Page: 1